Corporate ActionJul 15, 2026, 05:06 PM
Autonomix Medical Secures $2.6M via Warrant Inducement Offer
AI Summary
Autonomix Medical, Inc. announced a warrant inducement offer, securing approximately $2.6 million in gross proceeds. The company reduced the exercise price of existing Series C warrants to $6.00 per share, prompting the holder to exercise 428,731 shares. In consideration, Autonomix issued new Series D-1 and D-2 unregistered warrants, each for 428,731 shares, with an exercise price of $5.75 per share and a 5.5-year term. Maxim Group LLC acted as the warrant solicitation agent.
Key Highlights
- Autonomix Medical entered into a warrant inducement offer letter on July 13, 2026.
- The exercise price of existing Series C warrants was reduced to $6.00 per share.
- The holder agreed to exercise existing warrants for 428,731 shares of common stock.
- The company expects to receive approximately $2.6 million in gross proceeds from the exercise.
- New Series D-1 and D-2 unregistered warrants were issued, each for up to 428,731 shares.
- The new warrants have an exercise price of $5.75 per share and a 5.5-year term.
- Maxim Group LLC served as warrant solicitation agent, receiving a 7.0% cash fee.
- The company agreed to file a registration statement for the resale of the new warrant shares.
Price Impact
More from AMIX